We cannot approach the week ahead without acknowledging the impact of the week just passed. There is no getting around it. The U.S. Federal Reserve raised the Fed Funds Rate and kept its forecasts hawkish despite the stagflation obstacle some investors saw. But it is an illusion; inflation is only missing in action, and I believe on its way. So take your bitter medicine Mr. Market, and like it, because it is necessary. The Fed's positioning and the uncertainty about the U.S. economy should keep a lid on the market for now. The ongoing investigation of the President and the sluggish progress of key cogs of his agenda (tax reform) add drag as well, though if we get progress, the line will be cut for the market to race higher. We're just not there yet, but we do have rising geopolitical tensions and a Special Counsel investigation to digest daily. And with the long days of summer ahead of us, stocks may have marked highs we will not see again for a while.
The SPDR S&P 500 (NYSE: SPY) closed the busy news week down 0.3%, though stocks might have reacted more violently considering everything that happened. The SPDR Dow Jones (NYSE: DIA) gained by 0.4%; the PowerShares QQQ (NASDAQ: QQQ) declined by 1.3%; and the iShares Russell 2000 (NYSE: IWM) dropped by 1.0%. The PowerShares DB US Dollar Bull (NYSE: UUP) fell by 0.1%; the United States Oil (NYSE: USO) fell by 2.6%; the SPDR Gold Trust (NYSE: GLD) dropped by 1.0% and the PIMCO Active Bond Exchange Fund (NYSE: BOND) gained by 0.3%.
In the week ahead, you can bet your bottom dollar the investigation of Russia's election meddling and now the President of the United States as well, according to his tweet, will key the start of the week with tension. But as we progress, the market will take its lead from relevant developments. So let's examine the economic schedule for starters.
The Economic Schedule
As always, the week following an FOMC Policy Meeting presents a parade of Federal Reserve officials. The schedule of speakers will therefore offer more color on Fed thinking. It could drive some volatility in the week ahead but I wouldn't count on it with the FOMC clearly expressing itself just a few days ago. More importantly, economic data will now be looked to to justify the Fed perspective.
On Monday, we will hear from New York Federal Reserve Bank President William Dudley in the morning and Chicago Fed Bank President Charles Evans in the evening. There will be no critical data reported in America Monday otherwise, so expect the full focus of investors to be on analyst commentary on the Amazon (NASDAQ: AMZN), Whole Foods Market (NYSE: WFM) deal, the Fed speakers and any developments around the investigation by Special Counsel Mueller.
Three more Fed speakers highlight Tuesday's schedule, with Federal Reserve Vice Chairman Stanley Fischer and Boston Federal Reserve Bank President Eric Rosengren scheduled to make news before the market open. In the afternoon we will hear from Dallas Federal Reserve Bank President Robert Kaplan.
The only other data on tap for the day is the Current Account for Q1, due at 8:30 AM EDT. The consensus of economists expect the current account deficit to widen to $121.8 billion, from $112.4 billion in the fourth quarter.
Tuesday's earnings schedule is very interesting and highlights Adobe Systems (NASDAQ: ADBE), FedEx (NYSE: FDX), HB Fuller (NYSE: FUL), Korn/Ferry Int'l (NYSE: KFY), La-Z-Boy (NYSE: LZB), Lennar (NYSE: LEN) and Red Hat (NYSE: RHT). Housing industry strength will likely benefit most relative corporate reporters, including possibly builder Lennar, building products supplier HB Fuller and home furniture maker La-Z-Boy. FedEx is also reporting and offers insight into economic health. I'll be keeping my eye on all these firms and likely reporting on at least one of them in the days ahead.
Wednesday's economic schedule highlights housing data, with Existing Home Sales (NYSE: IYR) due for the month of May. Economists see the annual pace of sales edging lower to 5.55 million in May, down from 5.57 million in April. Existing home sales were up 1.6% year-to-year in April.
I'm still looking for the housing market to recover in coming months, as it did last year on new seasonal or special effect (seen last 3 years) economists are still trying to understand. April was a relatively poor month and economists are playing it close to the vest here for May with a conservative consensus forecast close to the prior month report. Maybe we'll do better...
The existing home market makes up the majority of U.S. home sales, but I think a healthy market is characterized by a larger percentage of new home sales to total sales.
Wednesday's earnings is highlighted by reports from Actuant (NYSE: ATU), Carmax (NYSE: KMX), Cyanotech (NASDAQ: CYAN) and Winnebago Industries (NYSE: WGO). Let's look at Carmax and Winnebago for anecdotal insight into the state of consumer discretionary spending.
Thursday's data will be led by Leading Economic Indicators, due at 10:00 AM EDT. This report for May is expected by economists to show a 0.3% increase, matching the mark set in April. The consensus range varies one-tenth of a percentage point either way, but this data is critical to investors today, so the slightest swing will move the market. Good news is good news here and justifies the Fed's rate action and still serves stocks; bad news is bad news and hurts us.
The rest of the day's data is marginally important to market direction and velocity. The FHFA House Price Index will catch some eyes, simply because housing prices are an important component for inflation measures. Economists see a 0.5% increase for April's data reported today. That would mark a slowing from the 0.6% gain seen for March. On a year-to-year basis, prices were up 6.2% in March, and that illustrates how hot home prices have been on lacking supply and an improving economy and job market.
The Kansas City Fed Manufacturing Index, due this day, is a measure of Midwest manufacturing. Last month, the index marked 8.0; positive readings indicate economic expansion.
Thursday's earnings schedule highlights the reports of Accenture (NYSE: ACN), Apogee Enterprises (NASDAQ: APOG), Barnes & Noble (NYSE: BKS), Bed Bath & Beyond (NASDAQ: BBBY), Carnival (NYSE: CCL), Commercial Metals (NYSE: CMC), Hain Celestial Group (NASDAQ: HAIN), Methode Electronics (NYSE: MEI), SYNNEX (NYSE: SNX), Sonic (NASDAQ: SONC) and iKang Healthcare (NASDAQ: KANG). Again, my focus will be on consumer discretionary spending indications from Carnival and also possible housing strength benefits at Bed Bath & Beyond.
Bill Dudley is back on Friday, along with Fed speakers Bullard, Mester and Powell, so things might get interesting to close out the first summer Friday. Don't kid yourself; we are entering the period of light trading volume as money managers (too many anyway) spend their weekends (long ones) watching the markets from the beach - I hear Shelter Island is the place to be from a trader friend I lost several years ago tragically the day after Father's Day. Steve Koufakis, I'll raise a drink to you this weekend, and I'll spill some ouzo for you too.
As for data, New Home Sales (NYSE: PHM) is due for May at 10:00 AM EDT. Economists expect the annual pace of sales to recover some, rising to 590K after dropping sharply in April to 569K. Oftentimes, on a big move like that, we see revisions the following month, so I would not be surprised to see one here for April.
A shout out to Philly-based builder Toll Brothers (NYSE: TOL), a close to home company I valued and owned shares of in graduate school (and did well with). I got to meet one of the Toll Brothers and tell him about it not long thereafter. And oh by the way, Toll Brothers was pointing out tightness in its relative labor market years ago at the Emerald Research Groundhog Day Conference. Look for more companies to be doing the same in the months ahead as labor market tightness becomes an endemic problem. It should ignite inflation.
Markit will be reporting its PMI Composite Flash measure Friday too, with economists looking for it to hold near the prior month level (consensus forecast at 53.8 for June). Manufacturing is seen gaining slightly to 52.6 and Services is seen falling to 53.7, from 54.0. Readings above 50.0 mark economic expansion.
The earnings schedule includes BlackBerry (NASDAQ: BBRY) and Finish Line (NASDAQ: FINL).
In conclusion, keep your eye on all of the above, and one eye on the President's Twitter account, as it all matters nowadays for stocks... sad! For more of my musings on the market, follow the column here at Seeking Alpha.
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Original post:
Week Ahead - Mr. Market Takes His Bitter Medicine - Seeking Alpha
- Yes, But. The Annotated Atlantic. - November 7th, 2009 [November 7th, 2009]
- Health Insurance Benefit Costs by Region - November 8th, 2009 [November 8th, 2009]
- For an Operator, Please Press... - November 8th, 2009 [November 8th, 2009]
- Pollyanna With a Pen: Maine Governor Signs 18 New Health Care Bills into Law - November 8th, 2009 [November 8th, 2009]
- AMA Sounds the Alarm, Medicare Making Yet Another Attempt to Cut Reimbursement - November 8th, 2009 [November 8th, 2009]
- Mass Governor Asks Blue Cross to Keep Higher Employer Contribution - November 8th, 2009 [November 8th, 2009]
- Lifespan and Care New England Plan Monopoly (Again) - November 8th, 2009 [November 8th, 2009]
- Dirigo Health: Con Artists, Liars, and Thieves? - November 8th, 2009 [November 8th, 2009]
- New Orleans: Health Challenges - November 8th, 2009 [November 8th, 2009]
- August a Flurry of Activity - November 8th, 2009 [November 8th, 2009]
- Maine's Dirigo Health Savings One-Third of Original Estimate - November 8th, 2009 [November 8th, 2009]
- “Methodolatry”: My new favorite term for one of the shortcomings of evidence-based medicine - November 8th, 2009 [November 8th, 2009]
- Suzanne Somers’ Knockout: Dangerous misinformation about cancer (part 1) - November 8th, 2009 [November 8th, 2009]
- A science-based blog about GMO - November 8th, 2009 [November 8th, 2009]
- A Not-So-Split Decision - November 8th, 2009 [November 8th, 2009]
- Military Medicine in Iraq - November 8th, 2009 [November 8th, 2009]
- The effective wordsmithing of Amy Wallace - November 8th, 2009 [November 8th, 2009]
- A Science Lesson from a Homeopath and Behavioral Optometrist - November 8th, 2009 [November 8th, 2009]
- Join CFI in opposing funding mandates for quackery in health care reform - November 8th, 2009 [November 8th, 2009]
- Mainstreaming Science-Based Medicine: A Novel Approach - November 8th, 2009 [November 8th, 2009]
- Those who live in glass houses… - November 8th, 2009 [November 8th, 2009]
- J.B. Handley of the anti-vaccine group Generation Rescue: Misogynistic attacks on journalists who champion science - November 8th, 2009 [November 8th, 2009]
- When homeopaths attack medicine and physics - November 8th, 2009 [November 8th, 2009]
- The cancer screening kerfuffle erupts again: “Rethinking” screening for breast and prostate cancer - November 8th, 2009 [November 8th, 2009]
- All Medicines Are Poison! - November 8th, 2009 [November 8th, 2009]
- When Loud Wins: Will Your Tax Dollars Pay For Prayer? - November 8th, 2009 [November 8th, 2009]
- It’s All in Your Head - November 8th, 2009 [November 8th, 2009]
- The Skeptical O.B. joins the Science-Based Medicine crew - November 8th, 2009 [November 8th, 2009]
- The Tragic Death Toll of Homebirth - November 8th, 2009 [November 8th, 2009]
- What’s the right C-section rate? Higher than you think. - November 8th, 2009 [November 8th, 2009]
- Recombinant Human Antithrombin – Milking Nanny Goats for Big Bucks - December 13th, 2009 [December 13th, 2009]
- Does C-section increase the rate of neonatal death? - December 13th, 2009 [December 13th, 2009]
- Man in Coma 23 Years – Is He Really Conscious? - December 13th, 2009 [December 13th, 2009]
- Why Universal Hepatitis B Vaccination Isn’t Quite Universal - December 13th, 2009 [December 13th, 2009]
- Ontario naturopathic prescribing proposal is bad medicine - December 13th, 2009 [December 13th, 2009]
- Naturopaths and the anti-vaccine movement: Hijacking the law in service of pseudoscience - December 13th, 2009 [December 13th, 2009]
- The Institute for Science in Medicine enters the health care reform fray - December 13th, 2009 [December 13th, 2009]
- Neti pots – Ancient Ayurvedic Treatment Validated by Scientific Evidence - December 13th, 2009 [December 13th, 2009]
- Early Intervention for Autism - December 13th, 2009 [December 13th, 2009]
- A temporary reprieve from legislative madness - December 13th, 2009 [December 13th, 2009]
- A critique of the leading study of American homebirth - December 13th, 2009 [December 13th, 2009]
- Lose those holiday pounds - December 13th, 2009 [December 13th, 2009]
- Endocrine disruptors—the one true cause? - December 13th, 2009 [December 13th, 2009]
- Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome - December 13th, 2009 [December 13th, 2009]
- Evidence in Medicine: Experimental Studies - December 13th, 2009 [December 13th, 2009]
- Midwives and the assault on scientific evidence - December 13th, 2009 [December 13th, 2009]
- The Mammogram Post-Mortem - December 13th, 2009 [December 13th, 2009]
- An Influenza Recap: The End of the Second Wave - December 13th, 2009 [December 13th, 2009]
- The End of Chiropractic - December 13th, 2009 [December 13th, 2009]
- Cell phones and cancer again, or: Oh, no! My cell phone’s going to give me cancer! (revisited) - December 20th, 2009 [December 20th, 2009]
- Another wrinkle to the USPSTF mammogram guidelines kerfuffle: What about African-American women? - December 20th, 2009 [December 20th, 2009]
- Acupuncture, the P-Value Fallacy, and Honesty - December 20th, 2009 [December 20th, 2009]
- The One True Cause of All Disease - December 20th, 2009 [December 20th, 2009]
- Communicating with the Locked-In - December 20th, 2009 [December 20th, 2009]
- Are the benefits of breastfeeding oversold? - December 20th, 2009 [December 20th, 2009]
- Measles - December 20th, 2009 [December 20th, 2009]
- Radiation from medical imaging and cancer risk - December 21st, 2009 [December 21st, 2009]
- Multiple Sclerosis and Irrational Exuberance - December 21st, 2009 [December 21st, 2009]
- Medical Fun with Christmas Carols - December 22nd, 2009 [December 22nd, 2009]
- Lithium for ALS – Angioplasty for MS - December 23rd, 2009 [December 23rd, 2009]
- “Toxins”: the new evil humours - December 24th, 2009 [December 24th, 2009]
- 2009’s Top 5 Threats To Science In Medicine - December 24th, 2009 [December 24th, 2009]
- Buteyko Breathing Technique – Nothing to Hyperventilate About - December 26th, 2009 [December 26th, 2009]
- The Graston Technique – Inducing Microtrauma with Instruments - December 29th, 2009 [December 29th, 2009]
- The “pharma shill” gambit - December 29th, 2009 [December 29th, 2009]
- Ginkgo biloba – No Effect - December 30th, 2009 [December 30th, 2009]
- Oppose “Big Floss”; practice alternative dentistry - January 1st, 2010 [January 1st, 2010]
- Causation and Hill’s Criteria - January 3rd, 2010 [January 3rd, 2010]
- The life cycle of translational research - January 10th, 2010 [January 10th, 2010]
- The anti-vaccine movement strikes back against Dr. Paul Offit - January 10th, 2010 [January 10th, 2010]
- Osteoporosis Drugs: Good Medicine or Big Pharma Scam? - January 10th, 2010 [January 10th, 2010]
- Acupuncture for Hot Flashes - January 10th, 2010 [January 10th, 2010]
- The case for neonatal circumcision - January 10th, 2010 [January 10th, 2010]
- A victory for science-based medicine - January 10th, 2010 [January 10th, 2010]
- James Ray and testosterone replacement therapy (TRT) - January 10th, 2010 [January 10th, 2010]
- The Water Cure: Another Example of Self Deception and the “Lone Genius” - January 12th, 2010 [January 12th, 2010]
- Be careful what you wish for, Dr. Dossey, you just might get it - January 13th, 2010 [January 13th, 2010]
- You. You. Who are you calling a You You? - January 15th, 2010 [January 15th, 2010]
- The War on Salt - January 16th, 2010 [January 16th, 2010]
- Is breech vaginal delivery safe? - January 16th, 2010 [January 16th, 2010]